關於 grail illumina ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. Illumina completes $8B Grail acquisition, companies remain ...

Grail was founded in 2016 and spun out as a standalone company powered by Illumina's NGS technology for developing data science and machine learning for ...

#12. Illumina最大收購案80億美元收購癌症液態活檢明星公司Grail

美國時間21日，Illumina正式宣布，將以80億美元收購癌症早期診斷明星公司Grail，包含35億美元和45億美元的股票，是Illumina有史以來最大的一筆交易，預計於明年(2021 ...

#13. Illumina Makes First Imprint on GRAIL with New CEO | BioSpace

The leadership change comes two months after Illumina acquired GRAIL and its multi-cancer early detection (MCED) blood test dubbed Galleri.

#14. Illumina Acquires GRAIL to Accelerate Patient ... - PR Newswire

SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company ...

#15. Illumina / Grail : The European Commission Cries “Halt!”

Illumina / Grail : The European Commission Cries “Halt!” · a time constraint: these measures would be applicable until the final decision was ...

#16. GRAIL (company) - Wikipedia

GRAIL (company) ; American biotechnology and pharmaceutical company · 2015 · Menlo Park, California. ,. United States · Galleri test · Illumina.

#17. Regulatory Hurdles Block a Cancer Miracle - WSJ

The Federal Trade Commission last month wrapped up an administrative trial in which it seeks to block Illumina's $8 billion acquisition of Grail ...

#18. EU tells Grail to 'actively work on' alternatives to Illumina ...

The European Commission told cancer-test startup Grail to “actively work" on alternatives to its acquisition by U.S. gene-sequencing giant ...

#19. Affaire Illumina / Grail : La Commission européenne Dit « Pause

Ce qui a été le cas, pour la première fois dès le 19 avril 2021, dans la médiatique affaire Illumina/Grail où six autorités nationales de ...

#20. A Gene Sequencing Pioneer Battles Over What It Can Buy

Grail uses Illumina's gene-sequencing technology, but it is in a different market. In traditional antitrust terms, the Illumina-Grail deal ...

#21. Ahead of expected EU objections, Illumina defends Grail ...

Illumina founded Grail and spun it out in 2016, but announced re-acquisition plans in September 2020. That news came just two weeks after ...

#22. Illumina completes acquisition of multi-cancer test developer ...

Illumina has completed the acquisition of Grail for $8bn to accelerate patient access to the latter's multi-cancer early-detection test.

#23. Illumina purchases Grail without clearance from FTC or ...

Grail is developing blood tests that aim to detect multiple types of cancer early, before they become deadly. Illumina is the leading maker of ...

#24. Illumina And Grail Run Into First-Ever Interim Measure For ...

On August 18, 2021, U.S. gene-sequencing company Illumina publicly announced it had acquired Grail, a start-up that has developed ...

#25. Illumina Challenges EU in Court, Accuses Regulators of ...

Illumina this week criticized EU regulators for their scrutiny of its $8 billion cash-and-stock takeover of Grail though the cancer test ...

#26. Would Illumina's acquisition of GRAIL constrict the expansion ...

Earlier this year, the Federal Trade Commission's (FTC) posed a roadblock in the path of sequencing giant Illumina's $7.1 billion proposed ...

#27. Illumina is Committed to Bringing Lifesaving GRAIL Test to ...

Illumina's re-acquisition of GRAIL means that millions of citizens across the European Economic Area (EEA) will be able to access ...

#28. Illumina/Grail: bio-tech companies in the firing line as the ...

The DNA sequencing giant Illumina is locked in a battle with the European Commission (EC) over its $7.1 billion acquisition of Grail.

#29. JP Morgan Downgrades Illumina to Neutral on Grail Deal

Along with the downgrade, the investment bank also lowered its December 2021 price target for Illumina from $390 to $280.

#30. Illumina Spinoff GRAIL to Trial Liquid Biopsies for Early ...

January 11, 2016 | Illumina, the dominant manufacturer of DNA sequencing technology, has formed a spinoff company called GRAIL to experiment ...

#31. FTC trial over Illumina's acquisition of Grail kicks off - The San ...

Last September, Illumina announced plans to acquire Grail, celebrating the deal as a homecoming of sorts. Grail spun out of Illumina in 2016 to ...

#32. Illumina Completes GRAIL Acquisition Without Approval From ...

Illumina has acquired GRAIL Inc. for $7.1 billion despite ongoing legal proceedings from the FTC and EU antitrust regulators.

#33. Illumina-Grail Acquisition Gets FTC Trial. What to Know.

Federal Trade Commission lawyers will present three weeks of evidence for their argument that the merger will allow Illumina (ticker: ILMN) to ...

#34. Illumina/GRAIL acquisition - Allen & Overy

Illumina /GRAIL acquisition: first use of the European Commission's new referral policy ...

#35. Illumina to Acquire GRAIL to Launch New Era of Cancer ...

Illumina and GRAIL have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion.

#36. Illumina-Grail review sees EU regulator weighing matters of ...

EU regulators grappling with the Illumina-Grail deal have to contend with two conflicting interests.

#37. Illumina closes Grail deal without EU approval - Global ...

Illumina has closed its €5.9 billion acquisition of Grail despite an ongoing EU Phase II probe, reiterating its claims that the European ...

#38. In Brief This Week: Grail, Illumina, Veracyte, Aspira Women's ...

Illumina is planning to acquire Grail for approximately $8 billion in cash and stock. Grail's R&D expenses for the quarter totaled $48 ...

#39. Illumina/GRAIL (M.10188) | Legal Guidance | LexisNexis

See further, timeline. Case facts. Outline, European Commission merger investigation into the proposed acquisition by GRAIL. Inc. of Illumina ...

#40. Illumina wants to bring liquid biopsy spinout Grail back in-house

Cancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite filing for an initial public ...

#41. Is the Illumina–GRAIL Saga an Outlier, or the Future?

By the time Illumina Inc. closed its $7.1 billion merger with GRAIL Inc. Aug. 18, it had seen more than its share of novel regulatory twists ...

#42. Illumina to Acquire Cancer Diagnostics Developer Grail in $8B ...

Grail is set to be acquired for $8 billion by Illumina, the gene sequencing giant that formed the cancer diagnostics developer and spun it ...

#43. EU Is Concerned Illumina Deal For Grail Could Hurt Innovation -

US life sciences company Illumina's proposed acquisition of cancer test maker Grail could curb innovation and competition, EU antitrust.

#44. Illumina/GRAIL: Testing Vestager's effort to expand EU merger ...

Illumina offers genomic sequencing instruments, while GRAIL is a healthcare firm that develops blood-based cancer tests based on genomic ...

#45. Illumina to Acquire GRAIL to Launch New Era ... - Business Wire

GRAIL was founded by Illumina in 2016 and was spun out as a standalone company, powered by Illumina's NGS technology, to develop ...

#46. EU threatens Illumina for closing $8B Grail deal while still ...

Illumina and Grail have a chance to respond to the Commission's objections before the imposition of the interim measures.

#47. With Challenge of Illumina-Grail Merger, Biden Antitrust Policy ...

With Challenge of Illumina-Grail Merger, Biden Antitrust Policy Claims its First Victim: Cancer Patients. WLF Legal Pulse. Issues:.

#48. Illumina以80亿美元收购Grail 进军癌症早筛市场 - 第一财经

美国基因测序公司Illumina（因美纳）周一宣布将以价值80亿美元的现金加股票交易形式，收购癌症筛查初创公司Grail，正式进军癌症早筛领域。

#49. Illumina Snags Third-Quarter Beat After $7.1 Billion Grail Buyout

Illumina stock toppled Friday despite the DNA sequencing giant's third-quarter beat in its first quarter after buying cancer-screening ...

#50. Form 8-K - SEC.gov

On September 20, 2020, Illumina, Inc. ... Pursuant to the Merger Agreement, First Merger Sub will merge with and into Grail (the “Merger”), with Grail continuing ...

#51. Commission issues historic interim measures in Illumina/Grail ...

The European Commission has adopted interim measures in the Illumina/Grail merger case. The Commission is currently investigating the case, ...

#52. Illumina to acquire its spin-out GRAIL for $8bn in drive to ...

Illumina is to reacquire its spin-out GRAIL for $8billion ahead of the commercialisation of a blood screening test for multiple cancers.

#53. Illumina Bid for Cancer-Screening Firm Grail Challenged by FTC

The FTC is challenging Illumina's plan to acquire the stake it doesn't already own in Grail, a maker of a noninvasive biopsy test that screens ...

#54. EU tests new “killer acquisition” strategy on Illumina/Grail

EU tests new “killer acquisition” strategy on Illumina/Grail. United Kingdom | Video | October 2021 | 08:26 ...

#55. The “Google of genomics” meets the techbashers of antitrust

Has Illumina found the holy GRAIL? ... IN 2013 MEREDITH HALKS MILLER, a laboratory director at Illumina, the world's biggest gene-sequencing ...

#56. Illumina高价收购打乱GRAIL上市节奏，公然与自家客户“抢食 ...

业内人士对生辉表示，Illumina 用80 亿美元收购是相当划算的，它对于GRAIL 的数据掌握以及技术成熟程度的理解和市场不太一样，而且GRAIL 的产品又将 ...

#57. Illumina completes Grail deal, despite lack of European approval

Illumina has completed its acquisition of cancer diagnostics developer Grail, almost a year after announcing the deal.

#58. EU antitrust regulators extend Illumina, Grail review deadline ...

The deal, unveiled in September 2020, would give Illumina access to Grail's flagship Galleri blood test used to diagnose cancers at early ...

#59. Illumina closes $8bn acquisition of cancer detection tests ...

Illumina has closed the acquisition of GRAIL, a US-based company focused on diagnostic tests for early detection for cancers, ...

#60. Illumina: Not All Rests With The Grail Acquisition - Seeking ...

ILMN first publicly announced its intention to acquire oncology testing company Grail back in September 2020. Grail was actually founded by ILMN ...

#61. Illumina to Acquire GRAIL to Launch ... - McKesson Ventures

GRAIL and Illumina have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon ...

#62. Illumina completes $7.1 billion deal for cancer test maker Grail

Illumina completed its $7.1 billion acquisition of Grail, a Menlo Park, Calif.-based developer of liquid biopsies for early cancer detection ...

#63. Illumina CEO on why the company moved forward ... - CNBC

#64. Illumina receives US FTC additional information request over ...

Illumina, which established Grail in 2015, already holds 14.5% of the company's outstanding shares. The company plans to fund the ...

#65. Commission opens Phase II investigation into proposed ...

... 6(1)(c) of the EU Merger Regulation, to initiate an in-depth Phase II investigation to assess the proposed acquisition of GRAIL by Illumina.

#66. Illumina 'Pushes Back' on EC's 'PushBack' of Grail Buy

Illumina has filed an action to annul the European Commission's decision to have the Grail acquisition reviewed. About a week ago, ...

#67. Illumina Promotes COO Bob Ragusa To CEO Of GRAIL

Illumina appointed Bob Ragusa has been appointed as CEO of GRAIL, a healthcare company whose mission is focused on multi-cancer early ...

#68. 監管機構反對聲中Illumina完成收購Grail - 信報網站hkej.com

美國生物科技公司Illumina雖面對監管部門的反對，周三公布已經完成斥資71億美元收購癌病檢測用品生產商Grail的交易。 美國聯邦貿易委員會(FTC)與歐盟 ...

#69. Illumina reaches for the cancer testing GRAIL - PHG Foundation

Illumina reaches for the cancer testing GRAIL ... GRAIL, to develop a 'pan-cancer screening test' using patient blood samples.

#70. Has Illumina found the Holy Grail? - BSIC

Grail – privately held. Introduction. On September 21 st, 2020, the biotech pioneer Illumina agreed to buy the cancer screening start-up ...

#71. Illumina Buys Out Big Investors With $8B Acquisition Of Grail

Gene sequencing firm Illumina announced plans on Monday to buy cancer screening startup Grail in a cash-and-stock deal worth $8 billion.

#72. Illumina Acquires Grail Despite Ongoing Regulatory Scrutiny

NEW YORK – Illumina said on Wednesday that it has acquired Grail, even though the deal is still under review by regulators in the US and ...

#73. Illumina closes Grail takeover despite pending FTC trial

For now, Illumina is holding off on integrating Grail pending the regulatory and legal reviews. Evercore ISI analysts called it a "maverick move ...

#74. Illumina closes $8bn Grail merger - Front Line Genomics

Illumina has finalised its acquisition of Grail, defying both antitrust concerns from the EU and a pending legal challenge by the FTC.

#75. Illumina completes acquisition of GRAIL - Medical Laboratory ...

Illumina announced that it has acquired GRAIL, which focuses on early detection of multiple cancers, but will hold GRAIL as a separate ...

#76. Illumina acquires GRAIL to accelerate patient access to ...

San Diego-based biotechnology company Illumina has acquired GRAIL, a health care company focused on early detection of multiple cancers, ...

#77. Why Illumina Wants Grail Back So Badly | The Motley Fool

Liquid biopsy pioneer Grail is kind of like a boomerang for Illumina (NASDAQ:ILMN). The giant in gene-sequencing systems spun off Grail ...

#78. Illumina snaps up liquid biopsy-focused Grail for $8B - BioWorld

Following days of speculation, Illumina Inc. said today it will acquire liquid biopsy startup Grail Inc. for $8 billion in cash and stock, ...

#79. Illumina Launches GRAIL, Focused on Blood-Based Cancer ...

The new company, called GRAIL, will use its financing to build and scale a CLIA- and CAP-certified sequencing lab applying Illumina's ...

#80. 先发制人，基因测序老大Illumina未经审查许可完成对Grail的收购

Illumina 收购Grail的行为一直饱受争议。今年3月份，FTC便表示反对并对这项收购提起诉讼。彼时，Illumina当天的股价就大跌了6.7%。

#81. Illumina/Grail – FTC's First Vertical Merger Challenge in ...

The FTC alleges that Illumina's proposed acquisition of Grail would substantially lessen competition in the U.S. multi-cancer early detection ( ...

#82. Illumina buying cancer-screening spinout Grail in blockbuster ...

As part of the deal, Grail will receive $3.5 billion in cash, with another $4.5 billion earmarked for Illumina stock. The company set a deadline ...

#83. FTC's Drop Of Illumina-Grail Merger Case Raises Uncertainty

A federal judge recently dismissed the Federal Trade Commission's challenge of Illumina Inc.'s acquisition of Grail Inc., a cancer-screening ...

#84. Illumina: The Holy Grail of Issues for Certain Companies ...

Grail is a leading developer of a multi-cancer early detection (MCED) test under the brand name Galleri TM, and Illumina is a publicly-traded DNA ...

#85. Illumina CEO on why the company moved forward ... - YouTube

#86. A Single Blood Test For All Cancers? Illumina, Bill Gates And ...

It is launching a new startup, GRAIL (because such a test would be a holy grail for cancer doctors), with $100 million in funding. Illumina ...

#87. Biotech : le rachat de Grail par Illumina agace l'Union ...

Illumina avait jusqu'au 20 décembre pour conclure le rachat de Grail, sans quoi, elle aurait dû payer à la biotech des frais de résiliation de ...

#88. European Commission to investigate acquisition of ...

Illumina and GRAIL manufacture, among other products, products for tests for detecting cancer at a very early stage. The Netherlands Authority ...

#89. Illumina may buy back Grail - Drug Discovery and Development

Illumina may acquire Grail for more than $8 billion — four years after it spun out the cancer detection startup.

#90. Illumina's $8 Billion Acquisition of GRAIL - Cravath, Swaine ...

GRAIL, a healthcare company focused on multi-cancer early detection, was founded by Illumina, a global leader in DNA sequencing and array-based ...

#91. Illumina will pay $8B to acquire Grail, the Bill Gates and Jeff ...

Cancer detection startup Grail will be acquired by DNA sequencing machine maker Illumina for $8 billion in cash and stock, the companies ...

#92. Latham & Watkins Advises GRAIL in Acquisition By Illumina

Illumina, Inc. and GRAIL, a healthcare company whose mission is focused on multi-cancer early detection, announced that they have entered ...

#93. @illumina buys @GrailBio for $8 billion - Enseqlopedia

Wow Illumina just spent $8 billion buying GRAIL; arguably the leader in methylation-based early detection of cancer with their Galleri test ...

#94. 7 Things to Know About GRAIL's Spinout from Illumina - San ...

Illumina Inc.'s much-touted cancer test venture, GRAIL, is spinning out from its San Diego-based parent and raising $1 billion to develop ...

#95. The European Commission opens a review of Illumina's ...

The European Commission opens a review of Illumina's acquisition of Grail under the procedure of Article 22 of the 2004 Merger Regulation.

#96. Illumina cuts stake in Grail, strikes deals - C&EN

Illumina intends to reduce its ownership stake in the blood-based cancer detection firm Grail to below 20%. Illumina, a gene sequencing ...

#97. Illumina wants Grail back | Nature Biotechnology

Grail is back in Illumina's fold after the sequencing giant agreed in September to pay $8 billion in cash and stock for the liquid biopsy ...